This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 1490
From Proteopedia
(Difference between revisions)
| Line 26: | Line 26: | ||
'''''Diagram : Comparison of the Kinase Activities of Normal and Mutant TIE2 Receptors''''' | '''''Diagram : Comparison of the Kinase Activities of Normal and Mutant TIE2 Receptors''''' | ||
| - | (B) Cells infected with wild-type baculovirus (wt) or virus expressing normal TIE2 (R2) or mutant TIE2 (W2). Cells expressing the mutation at position 849 (Arginine | + | (B) Cells infected with wild-type baculovirus (wt) or virus expressing normal TIE2 (R2) or mutant TIE2 (W2). Cells expressing the mutation at position 849 (Arginine → Tryptophan) have an autophosphorylation activity 6 to 10 times higher than wild cells. |
[[Image:Venous Malformations Diagram.jpg]] | [[Image:Venous Malformations Diagram.jpg]] | ||
| + | |||
With this mutation, Venous Malformations (VMs) contain a Disproportionately high ratio of Endothelial Cells (ECs) to Smooth Muscle Cells (SMCs) | With this mutation, Venous Malformations (VMs) contain a Disproportionately high ratio of Endothelial Cells (ECs) to Smooth Muscle Cells (SMCs) | ||
| - | Pictures of immunohistochemistry of VMs with Antibodies against Smooth Muscle Cells 𝛂-Actin | + | '''''Pictures of immunohistochemistry of VMs with Antibodies against Smooth Muscle Cells 𝛂-Actin''''' |
B = Abnormal channels | B = Abnormal channels | ||
| + | |||
C = Normal veins (v) and arteries (a) | C = Normal veins (v) and arteries (a) | ||
| - | + | ||
Scale bars, 200 𝛍m. | Scale bars, 200 𝛍m. | ||
| + | |||
| + | Antibodies directed against SMCs 𝛂-Actin from cells with VMs show that the vessels have a specific and abnormal staining (B) compared to normal vessels (C) | ||
| + | |||
== Relevance == | == Relevance == | ||
Revision as of 15:30, 10 January 2019
| This Sandbox is Reserved from 06/12/2018, through 30/06/2019 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1480 through Sandbox Reserved 1543. |
To get started:
More help: Help:Editing |
Kinase Domain of Tyrosine-protein kinase receptor TIE-2 (PDB:6MWE)
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644

